Recent

% | $
Quotes you view appear here for quick access.

ImmunoGen, Inc. Message Board

  • johngunn51 johngunn51 Apr 23, 2013 4:10 PM Flag

    STML /SGEN semi off thread

    One of the reasons Seattle Genetics stock has gone so high is they are working w StemLine on cancer stem cell targets, very fascinating stuff that could be as close as any oncology treatment has ever come to the silver bullet. Obmeier of SGEN has taken a seat on the STML board. STML public but very closely held. Run by the guy who started Keryx and the guy who invented herbitux @ImClone. BTW, my guy at Genentech says Kadcyla is selling as fast as they can make it. IMGN doesn't report royalties until the quarter after Roche reports sales, but all the comps Y/Y and sequentially quarterlies will be really good for Immunogen next 24 months.......

 
IMGN
3.13-0.05(-1.57%)Jun 29 4:00 PMEDT